Causes of death across steatotic liver disease (SLD) subtypes remain incompletely characterized in routine clinical practice. We aimed to quantify and compare cause-specific mortality in SLD.

YouTube video by EASL - Home of Hepatology

Data on cause-specific mortality in metabolic dysfunction-associated steatotic liver disease (MASLD) are limited. We aimed to determine the rate and risk of death from different causes in patients wit...

Description: The Kidney Disease: Improving Global Outcomes (KDIGO) organization updated its existing clinical practice guideline in 2024 to provide guidance on the evaluation, management, and treatmen...

Results from the phase 2 MATCH01 clinical trial of autologous monocyte-derived macrophage therapy for liver cirrhosis revealed no liver-related severe adverse events or deaths in the treatment group.

Festive indulgence is an occupational hazard for our deputy food editor, so who better to try a new year liver MoT?

Despite the prevalence and quality of life impact cramps have on patients with cirrhosis, no widely used clinical practice guidelines on management exist. Our systematic review, focusing only on rand...